Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Shares Outstanding (2020 - 2025)

NeuroPace has reported Shares Outstanding over the past 6 years, most recently at $33.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $33.6 million for Q4 2025, up 11.38% from a year ago — trailing twelve months through Dec 2025 was $33.6 million (up 11.38% YoY), and the annual figure for FY2025 was $33.6 million, up 11.38%.
  • Shares Outstanding for Q4 2025 was $33.6 million at NeuroPace, up from $33.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for NPCE hit a ceiling of $33.6 million in Q4 2025 and a floor of $470634.0 in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $26.0 million (2023), compared with a mean of $26.4 million.
  • Biggest five-year swings in Shares Outstanding: surged 11918.62% in 2021 and later grew 2.14% in 2022.
  • NeuroPace's Shares Outstanding stood at $24.5 million in 2021, then grew by 2.42% to $25.0 million in 2022, then increased by 11.09% to $27.8 million in 2023, then grew by 8.34% to $30.1 million in 2024, then rose by 11.38% to $33.6 million in 2025.
  • The last three reported values for Shares Outstanding were $33.6 million (Q4 2025), $33.3 million (Q3 2025), and $33.0 million (Q2 2025) per Business Quant data.